Evidence map›Paper›PMID 25344397›Full record

ArticleRNA (New York, N.Y.)2014

miRNAome analysis of the mammalian neuronal nicotinic acetylcholine receptor gene family.

Eric M Hogan, Alison P Casserly, Michael D Scofield, Zhongming Mou, Rubing Zhao-Shea, Chris W Johnson, Andrew R Tapper, Paul D Gardner

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eric M HoganBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Alison P CasserlyBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA UMMS MD/PhD Program, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Michael D ScofieldBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Zhongming MouBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Rubing Zhao-SheaBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Chris W JohnsonBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Andrew R TapperBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA UMMS MD/PhD Program, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA.
Paul D GardnerBrudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA UMMS MD/PhD Program, University of Massachusetts Medical School, Worcester, Massachusetts 01604, USA paul.gardner@umassmed.edu.

Funding

microRNA Regulation of the Nicotine Dependence Susceptibility Locus CHRNA5/A3/B4R21DA033543 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARDNER, PAUL D · 2013 to 2014
$458k
MicroRNA Regulation of Nicotine-Mediated BehaviorsR21DA031952 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARDNER, PAUL D, TAPPER, ANDREW R · 2012 to 2013
$443k
Modulation of Nicotine Reward-Associated Behaviors by MicroRNAsF30DA036312 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CASSERLY, ALISON PATRICE · 2014 to 2016
$98k
MicroRNA Regulation of Nicotinic Acetylcholine Receptor Expression and FunctionF31DA029386 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HOGAN, ERIC MATTHEW · 2011 to 2011
$9k
NIDA NIH HHS F30 DA036312NIDA NIH HHS F31 DA029386NIDA NIH HHS F31DA029386NIDA NIH HHS R21 DA031952NIDA NIH HHS R21DA031952NIDA NIH HHS R21 DA033543NIDA NIH HHS R21DA033543
6 · The paper itself

Abstract

Nicotine binds to and activates a family of ligand-gated ion channels, neuronal nicotinic acetylcholine receptors (nAChRs). Chronic nicotine exposure alters the expression of various nAChR subtypes, which likely contributes to nicotine dependence; however, the underlying mechanisms regulating these changes remain unclear. A growing body of evidence indicates that microRNAs (miRNAs) may be involved in nAChR regulation. Using bioinformatics, miRNA library screening, site-directed mutagenesis, and gene expression analysis, we have identified a limited number of miRNAs that functionally interact with the 3'-untranslated regions (3' UTRs) of mammalian neuronal nAChR subunit genes. In silico analyses revealed specific, evolutionarily conserved sites within the 3' UTRs through which the miRNAs regulate gene expression. Mutating these sites disrupted miRNA regulation confirming the in silico predictions. In addition, the miRNAs that target nAChR 3' UTRs are expressed in mouse brain and are regulated by chronic nicotine exposure. Furthermore, we show that expression of one of these miRNAs, miR-542-3p, is modulated by nicotine within the mesocorticolimbic reward pathway. Importantly, overexpression of miR-542-3p led to a decrease in the protein levels of its target, the nAChR β2 subunit. Bioinformatic analysis suggests that a number of the miRNAs play a general role in regulating cholinergic signaling. Our results provide evidence for a novel mode of nicotine-mediated regulation of the mammalian nAChR gene family.

Indexed as

3' Untranslated RegionsAnimalsBrainGene Expression RegulationIon ChannelsLigandsMammalsMiceMicroRNAsMutagenesis, Site-DirectedNicotineOrgan SpecificityReceptors, NicotinicSignal Transduction3' Untranslated RegionsIon ChannelsLigandsMicroRNAsNicotineReceptors, Nicotinicgene expressionmiR-542-3pmiRNA analysisnicotinic acetylcholine receptor

Identifiers

PMID25344397
PMCPMC4238110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.